Brachytherapy Market Summary
According to the report published by Allied Market Research, the global brachytherapy market garnered $0.83 billion in 2021, and is estimated to generate $1.6 billion by 2031, manifesting a CAGR of 7.1% from 2022 to 2031. The study analyzes the important strategies, drivers, competition, market dynamics, size, and important investment regions.
Market Dynamics & Key Sectors
- Market Growth: The market is expected to grow from USD 1.31 billion in 2026 to USD 2.53 billion by 2034.
- Types: High Dose Rate (HDR) is dominant, with increasing adoption of Image-Guided Brachytherapy (IGBT).
- Allied Products & Services: Includes radioactive seeds, applicators, afterloaders, imaging systems for planning, and treatment planning software.
- Key Drivers: Rising prevalence of cancer, demand for minimally invasive, localized treatments, and shorter treatment times.
- Regional Dominance: North America leads with a 45.7% share (2023), while Asia-Pacific is the fastest-growing region.
This is sometimes called internal radiation. Brachytherapy is an innovative cancer treatment that places radiation directly inside the tumor, or at the surgical margin allowing for a highly targeted treatment dose to be delivered to the target region, while limiting dose to surrounding, critical structures.
The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ https://www.alliedmarketresearch.com/request-sample/11487
Brachytherapy Market Segmentation
The brachytherapy market is segmented on the basis of product type, techniques, application, end user, and region. Depending on the product type, the market is classified into seeds, applicators & afterloaders, and electronic brachytherapy. Based on technique, the market is classified into high dose rate (HDR), and low dose rate (LDR). On the basis of application, the market is classified into gynecological cancer, prostate cancer, breast cancer, and others. On the basis of end user, it is fragmented into hospitals, specialty clinics, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Type of device: The brachytherapy market can be segmented based on the type of device used. Some of the major types of brachytherapy devices include:
- Applicators & afterloaders: Applicators are used to deliver brachytherapy seeds or capsules to the tumor site. Afterloaders are used to deliver brachytherapy sources to the tumor site for a specific period of time.
- Seeds & capsules: Brachytherapy seeds and capsules are small radioactive pellets that are implanted into the tumor site or placed in or near the tumor.
- Electronic brachytherapy devices: Electronic brachytherapy devices use X-rays or electrons to deliver brachytherapy treatment to the tumor site.
Technique: The brachytherapy market can also be segmented based on the technique used. Some of the major brachytherapy techniques include:
- High dose rate (HDR) brachytherapy: HDR brachytherapy delivers a high dose of radiation to the tumor site over a short period of time.
- Low dose rate (LDR) brachytherapy: LDR brachytherapy delivers a lower dose of radiation to the tumor site over a longer period of time.
Application: The brachytherapy market can also be segmented based on the application. Some of the major applications of brachytherapy include:
- Prostate cancer: Brachytherapy is a common treatment for prostate cancer.
- Breast cancer: Brachytherapy can also be used to treat breast cancer.
- Cervical cancer: Brachytherapy is a common treatment for cervical cancer.
- Other applications: Brachytherapy can also be used to treat other cancers, such as endometrial cancer, head and neck cancer, and skin cancer.
End-user: The brachytherapy market can also be segmented based on the end-user. Some of the major end-user segments include:
- Hospitals: Hospitals are the largest users of brachytherapy services.
- Cancer centers: Cancer centers are also major users of brachytherapy services.
- Private clinics: Private clinics are also increasingly offering brachytherapy services.
Request for Customization:
https://www.alliedmarketresearch.com/request-for-customization/11487
Brachytherapy Market Regional Growth Dynamics:
North America held the largest share in 2021, contributing to around two-fifths of the global brachytherapy market share, and is projected to maintain its dominant share in terms of revenue in 2031. However, the Asia-Pacific region is expected to manifest the fastest CAGR of 8.5% during the forecast period.
Competitive Landscape:
- Argon Medical Devices, Inc.
- Eckert & Ziegler BEBIG
- Elekta AB, iCAD, Inc.
- Siemens AG, isoray medical
- Merit Medical Systems, Inc.
- Theragenics Corporation
- IsoAid
- Carl Zeiss AG.
Future Outlook
The market is shifting towards advanced, image-guided, and personalized solutions, with increasing investment in healthcare infrastructure, especially in emerging economies.
Recent developments:
- New brachytherapy devices and techniques: New brachytherapy devices and techniques are being developed to improve the accuracy, precision, and effectiveness of brachytherapy treatment. For example, new brachytherapy devices are being developed that use image guidance to deliver radiation more precisely to the tumor site. New brachytherapy techniques are also being developed that use combinations of brachytherapy with other cancer treatments, such as surgery and radiation therapy, to improve patient outcomes.
- Advances in brachytherapy seeds and capsules: New brachytherapy seeds and capsules are being developed that are more effective and have fewer side effects. For example, new brachytherapy seeds and capsules are being developed that are made from materials that are more compatible with the body and that release radiation more slowly.
- Expansion of brachytherapy into new applications: Brachytherapy is being used to treat a wider range of cancers, including cancers of the head and neck, skin, and liver. For example, brachytherapy is being used to treat early-stage head and neck cancer in patients who are not eligible for surgery or radiation therapy.
Related Reports:
Immune Checkpoint Inhibitors Market From USD 40.1 Billion in 2022 to USD 189.4 Billion by 2032
USD 12.3+ Bn Nerve Repair and Regeneration Market Value Cross by 2030 | Allied Market Research
AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail themselves of an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
Get access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients in making strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies, and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality data and help clients in every way possible to achieve success. Each data presented in the reports published by us is extracted through primary interviews with top officials from leading companies in the domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int’l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Web: https://www.alliedmarketresearch.com
